期刊文献+

人血丙种球蛋白治疗手足口病合并脑炎的疗效 被引量:7

下载PDF
导出
摘要 目的观察人血丙种球蛋白治疗手足口病合并脑炎的疗效。方法将60例手足口病合并脑炎的患儿随机分为治疗组及对照组,两组均予降颅压、抗病毒、激素等对症支持治疗,治疗组在此基础上,应用人血丙种球蛋白1 g/(kg.d),连用2 d。对两组临床疗效进行比较。结果治疗组主要症状、体征缓解时间及脑脊液恢复时间、住院天数较对照组明显缩短(P<0.05)。结论人血丙种球蛋白治疗手足口病合并脑炎疗效确切,值得临床推广应用。
作者 李步云
出处 《实用药物与临床》 CAS 2012年第4期253-254,共2页 Practical Pharmacy and Clinical Remedies
  • 相关文献

参考文献4

二级参考文献14

  • 1Li L, He Y, Yang H, et al. Genetic characteristics of human en terovirus 71 and coxsackievirus A16 circulating from 1999 to 2004 in Shenzhen, People's Republic of China. J Clin Microbiol,2005,43 ( 8 ) :3835-3839.
  • 2Alexander JP Jr, Braden L, Pallansch MA, et al. Enterovirus 71 infections and neurologic disease-United States, 1977-1991. J Infect Dis, 1994,169 (4) :905-908.
  • 3Cardosa MJ,Krishnan S,Tio PH,et al. Isolation of subgenus B adenovirus during a fatal outbreak of enterovirus 71-associted hand, foot, and mouth disease in Sibu, Saramak. Lancet, 1999, 354(9183 ) :987-991.
  • 4Wang SM, Liu CC, Tseng HW, et al. Clinical spectrum of enterovirus 71 infection in children in southern Taiwan, with an emphasis on neurological complications. Clin Infect Dis, 1999, 29( 1 ) :184-190.
  • 5Huang FL,Jan SL, Chen PY,et al. Left ventricular dysfunction in children with fulminant enterovirus 71 infection:an evaluation of the clinical course. Clin Infect Dis,2002,34(7) :1020-1024.
  • 6Jackson GG, Muldoon RL. Viruses causing common respiratory infections in man. II. Enterovirus and paramyxoviruses. J Infect Dis, 1973,128 (3) :387-469.
  • 7Chang LY, King CC, Hsu KH, et al. Risk factors of enterovirus 71 infection and associated hand,foot, and mouth disease/herpangina in children during an epidemic in Taiwan. Pediatrics, 2002,109 (6) : e88.
  • 8Park SK, Park M, Ki M, et al. Transmission of seasonal outbreak of childhood enteroviral aspetic meningitis and hand- foot-mouth disease. J Korean Med Sci,2010,25 (5) :677-683.
  • 9Chang LY, Lin TY, Huang YC, et al. Comparison of enteroviruse 71 and coxsackie-virus A16 clinical illness during Taiwan enterovirus epidemic, 1998. Pediatr Infect Dis J, 1999,18 ( 2 ) : 1092-1096.
  • 10Ma H, He F, Wan J, et al. Glucocorticoid and pyrazolone treatment of acute fever is a risk factor for critical and life-threatening human enterovirus 71 infection during an outbreak in china,2008. Pediatr Infect Dis J,2010,29(6) :524-529.

共引文献87

同被引文献89

  • 1王琪.人免疫球蛋白治疗手足口病合并脑炎患儿的临床疗效分析[J].中国继续医学教育,2013,5(1):14-15. 被引量:2
  • 2翟晔.手足口病并发病毒性脑炎的治疗及护理观察[J].中国实用神经疾病杂志,2013,16(17):99-10. 被引量:1
  • 3董晓楠,应剑,陈应华.1970~2004年全球肠道病毒71型分离株的分子流行病学分析[J].科学通报,2007,52(9):1021-1027. 被引量:108
  • 4胡亚美,江载芳.实用儿科学[M].人民卫生出版社,2005:464-466.
  • 5Ooi MH, Wong SC, Mohan A, et al. Identification and validation of clinical predictors for the risk of neurological involvement in children with hand, foot, and mouth disease in Sarawak [ J 1. BMC Infect Dis,2009,9( 1 ) :1-12.
  • 6Chang LY,Lin TY,Hsu KH,et al. Clinical features and risk fac- tors of pulmonary oedema after enterovirus-71-related hand, foot, and mouth disease [ J]. Lancet, 1999,354 ( 9191 ) : 1682- 1686.
  • 7Li CC ,Yang MY,Chen RF,et al. Clinical manifestations and la- boratory assessment in an enterovirus 71 outbreak in southern Taiwan[ J:. Scand J Infect Dis,2002,34(2 ) :104-109.
  • 8Ooi MH, Solomom T, Podin Y, et al. Evaluation of differentclinical sample types in diagnosis of human enterovirus 71 asso- ciated hand foot and mouth disease[ J]. J Clin Microbio1,2007, 45(6) :1858-1866.
  • 9Ooi MH, Wong SC, Lewthwaite P, et al. Clinical features, diag- nosis,and management of enterovirus 71 [ J]. The Lancet Neu- rol,2010,9 ( 11 ) : 1097-1105.
  • 10Chang LY, King CC, Hsu KH, et al. Risk factors of enterovirus 71 infection and associated hand, foot, and mouth disease/her- pangina in children during an epidemic in Taiwan [ J ]. Pediat- rics,2002,109 (6) :e88.

引证文献7

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部